The biotechnological joint venture Richter-Helm belongs to the HELM AG since July 2007 respectively beginning of 2008.
The main contact person is Dr. Reinhard Rapp, Managing Director of the Richter-Helm.
Our main focus today:
Biopharmaceutical Development and Manufacturing
- Recombinant proteins
- Plasmid DNA
Biopharmaceutical Contract Services
- From strain development to API production
- Full analytical services
- Marketing and Sales
- Global in- and out-licensing of biopharmaceutical projects
- Full development up to finished product